Surgery, Vascular Surgery · Manati, PR
NPI
1770624116
Since 2007
Specialty
Surgery, Vascular Surgery
Code 2086S0129X
Group practices
0
Medicare group memberships
Hospitals
2
Hospital affiliations
Edificio Pedro Blanco Lugo 200, Suite 204
Manati, PR, 00674
Phone (787) 884-4744
Medicare paid, 2024
$5,967
55 services
Medicare patients, 2024
36
Average age 75
Drug cost, 2024
$155K
920 prescriptions
Company payments, 2025
$265
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Luis A Lopez Galarza was code 99213 (office e&m - established), 24 times for 20 patients. In total Luis A Lopez Galarza billed 55 services in 14 codes, and Medicare paid $5,967.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 24 | 20 | $37.80 | $907 |
By year: 2022 $8,104 for 80 services; 2023 $7,344 for 57 services; 2024 $5,967 for 55 services.
Medicare prescription drug claims, 2024
In 2024, the drug Luis A Lopez Galarza prescribed most often to Medicare patients was Cilostazol, with 586 prescriptions and refills. In total Luis A Lopez Galarza wrote 920 Medicare prescriptions that cost $155K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Cilostazol Generic | 586 | 640 | 182 | $13K |
| Xarelto Rivaroxaban | 214 | 234 | 70 | $132K |
| Clopidogrel Clopidogrel Bisulfate | 30 | 36 | 16 | $223 |
| Gabapentin Generic | 20 | 20 | Under 11 | $117 |
| Eliquis Apixaban | 14 | 14 | Under 11 | $8,450 |
Brand drugs: 237 claims; generic drugs: 683 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Luis A Lopez Galarza $265 ($265 in general payments such as food, travel and fees) from 3 companies. The largest payer was Medtronic, Inc. with $171.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.